International Trends in Head and Neck Cancer Mortality
Tsukasa Higashionna, Tatsuaki Takeda, Mariko Fujii, Nanami Sako, Keith Belangoy, Quynh Thi Vu, Ko Harada, Yoshito Nishimura, Hideharu Hagiya, Hirofumi Hamano, Michio Yamamoto, Yoshito Zamami, Toshihiro KoyamaImportance
Head and neck cancer (HNC) accounts for nearly 1 million new cases and approximately half a million deaths annually worldwide, representing a substantial global health burden. Despite an overall decline in mortality in many regions, patterns vary across anatomical subsites and countries.
Objective
To evaluate international and national mortality trends in HNC and its major anatomical subsites from 2001 to 2023.
Design, Setting, and Participants
This observational epidemiologic study analyzed population-based mortality data from the World Health Organization (WHO) Mortality Database for 73 countries between 2001 and 2023. Data collection was conducted in May 2025, and the data were analyzed between May and October 2025. Eligible countries had medium- to high-quality vital registration data. Age-standardized mortality rates (ASRs) were calculated using the new WHO World Standard Population. Country-specific trends from 2010 to 2023 were assessed using joinpoint regression among countries with at least 7 years of available data.
Main Outcomes and Measures
ASRs and average annual percentage change in HNC mortality overall and by anatomical subsite using population-based analysis.
Results
From 2001 to 2023, 2 000 066 HNC-related deaths (450 657 females; 1 549 409 males) were recorded. Internationally, ASRs decreased by 38.9%, with greater reductions among male individuals than among female individuals. Substantial divergence was observed across subsites: laryngeal cancer mortality decreased markedly (−50.1%), whereas increasing trends in oropharyngeal cancer mortality were observed in many countries in recent years, particularly in high-income countries such as the UK (average annual percentage change, 4.30%) and the US (average annual percentage change, 3.26%).
Conclusions and Relevance
Results of this study suggest that, although overall HNC-related ASRs have declined internationally, marked variation across subsites and countries persists. The contrasting trends between laryngeal and oropharyngeal cancers underscore the need for subtype-specific prevention strategies and continued global surveillance.